Michael Torres
Former - Chief Executive Officer CrossBridge Bio
Michael Torres, PhD, is Chief Executive Officer of CrossBridge Bio, where he leads the development of next‑generation ADC technologies and has successfully raised funding and built a high‑performing scientific team. Previously, he served as Entrepreneur‑in‑Residence at Texas Medical Center Innovation, supporting oncology startups, developing KOL networks, and securing venture participation. As Co‑Founder and former VP of R&D at ReCode Therapeutics, he helped transition academic science into a VC‑backed company, raising $160M and overseeing multidisciplinary R&D teams. With deep experience in cancer biology, gene therapy, and venture strategy, Dr. Torres brings a unique blend of scientific, operational, and business leadership.
